Annual Total Liabilities
$16.54 M
-$5.09 M-23.55%
31 December 2023
Summary:
Altimmune annual total liabilities is currently $16.54 million, with the most recent change of -$5.09 million (-23.55%) on 31 December 2023. During the last 3 years, it has fallen by -$3.19 million (-16.16%). ALT annual total liabilities is now -55.81% below its all-time high of $37.43 million, reached on 31 December 2008.ALT Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$14.49 M
-$6.33 M-30.40%
30 September 2024
Summary:
Altimmune quarterly total liabilities is currently $14.49 million, with the most recent change of -$6.33 million (-30.40%) on 30 September 2024. Over the past year, it has dropped by -$2.05 million (-12.42%). ALT quarterly total liabilities is now -62.98% below its all-time high of $39.14 million, reached on 30 September 2008.ALT Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALT Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -12.4% |
| 3 y3 years | -16.2% | -26.6% |
| 5 y5 years | +93.7% | +69.7% |
ALT Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -23.6% | at low | -33.0% | at low |
| 5 y | 5 years | -23.6% | +93.7% | -56.5% | +69.7% |
| alltime | all time | -55.8% | +414.8% | -63.0% | +7970.8% |
Altimmune Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $14.49 M(-30.4%) |
| June 2024 | - | $20.82 M(+35.0%) |
| Mar 2024 | - | $15.42 M(-6.8%) |
| Dec 2023 | $16.54 M(-23.5%) | $16.54 M(+2.3%) |
| Sept 2023 | - | $16.18 M(+3.7%) |
| June 2023 | - | $15.60 M(-19.4%) |
| Mar 2023 | - | $19.35 M(-10.6%) |
| Dec 2022 | $21.64 M(+9.7%) | $21.64 M(+6.9%) |
| Sept 2022 | - | $20.25 M(+31.7%) |
| June 2022 | - | $15.37 M(-26.1%) |
| Mar 2022 | - | $20.79 M(+5.4%) |
| Dec 2021 | $19.73 M(+2.6%) | $19.73 M(-28.6%) |
| Sept 2021 | - | $27.64 M(+73.0%) |
| June 2021 | - | $15.98 M(-10.3%) |
| Mar 2021 | - | $17.81 M(-7.4%) |
| Dec 2020 | $19.24 M(+125.3%) | $19.24 M(-42.2%) |
| Sept 2020 | - | $33.29 M(+44.6%) |
| June 2020 | - | $23.02 M(+86.6%) |
| Mar 2020 | - | $12.34 M(+44.5%) |
| Dec 2019 | $8.54 M(+32.6%) | $8.54 M(+21.9%) |
| Sept 2019 | - | $7.00 M(+21.8%) |
| June 2019 | - | $5.75 M(-5.0%) |
| Mar 2019 | - | $6.05 M(-6.0%) |
| Dec 2018 | $6.44 M(-55.1%) | $6.44 M(-51.1%) |
| Sept 2018 | - | $13.18 M(-16.5%) |
| June 2018 | - | $15.78 M(+9.8%) |
| Mar 2018 | - | $14.37 M(+0.1%) |
| Dec 2017 | $14.35 M(+131.8%) | $14.35 M(-16.9%) |
| Sept 2017 | - | $17.28 M(+16.2%) |
| June 2017 | - | $14.87 M(+455.3%) |
| Mar 2017 | - | $2.68 M(-56.8%) |
| Dec 2016 | $6.19 M(+92.7%) | $6.19 M(+49.0%) |
| Sept 2016 | - | $4.16 M(+12.9%) |
| June 2016 | - | $3.68 M(+18.4%) |
| Mar 2016 | - | $3.11 M(-3.3%) |
| Dec 2015 | $3.21 M | $3.21 M(-0.3%) |
| Sept 2015 | - | $3.22 M(-24.7%) |
| June 2015 | - | $4.28 M(-21.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $5.44 M(+46.9%) |
| Dec 2014 | $3.70 M(-62.2%) | $3.70 M(-29.4%) |
| Sept 2014 | - | $5.24 M(+20.3%) |
| June 2014 | - | $4.36 M(-27.9%) |
| Mar 2014 | - | $6.05 M(-38.3%) |
| Dec 2013 | $9.80 M(-11.4%) | $9.80 M(+5.8%) |
| Sept 2013 | - | $9.27 M(-18.5%) |
| June 2013 | - | $11.37 M(-5.5%) |
| Mar 2013 | - | $12.03 M(+8.7%) |
| Dec 2012 | $11.07 M(+59.2%) | $11.07 M(+1.9%) |
| Sept 2012 | - | $10.86 M(+5.8%) |
| June 2012 | - | $10.26 M(-6.6%) |
| Mar 2012 | - | $10.98 M(+58.0%) |
| Dec 2011 | $6.95 M(-53.6%) | $6.95 M(-2.1%) |
| Sept 2011 | - | $7.10 M(-42.0%) |
| June 2011 | - | $12.24 M(-6.1%) |
| Mar 2011 | - | $13.04 M(-13.0%) |
| Dec 2010 | $14.99 M(-53.4%) | $14.99 M(-54.6%) |
| Sept 2010 | - | $33.02 M(-1.3%) |
| June 2010 | - | $33.46 M(-0.7%) |
| Mar 2010 | - | $33.69 M(+4.7%) |
| Dec 2009 | $32.18 M(-14.0%) | $32.18 M(-9.3%) |
| Sept 2009 | - | $35.48 M(+8.5%) |
| June 2009 | - | $32.69 M(-12.0%) |
| Mar 2009 | - | $37.15 M(-0.7%) |
| Dec 2008 | $37.43 M(+43.7%) | $37.43 M(-4.4%) |
| Sept 2008 | - | $39.14 M(+0.3%) |
| June 2008 | - | $39.03 M(+49.5%) |
| Mar 2008 | - | $26.10 M(+0.2%) |
| Dec 2007 | $26.04 M(+56.7%) | $26.04 M(-8.6%) |
| Sept 2007 | - | $28.49 M(+91.0%) |
| Mar 2007 | - | $14.92 M(-10.2%) |
| Dec 2006 | $16.62 M(+18.8%) | $16.62 M(+16.4%) |
| Sept 2006 | - | $14.28 M(+0.9%) |
| June 2006 | - | $14.15 M(-0.3%) |
| Mar 2006 | - | $14.20 M(+1.5%) |
| Dec 2005 | $13.99 M | $13.99 M(+1.7%) |
| Sept 2005 | - | $13.76 M(+7564.6%) |
| June 2005 | - | $179.50 K |
FAQ
- What is Altimmune annual total liabilities?
- What is the all time high annual total liabilities for Altimmune?
- What is Altimmune quarterly total liabilities?
- What is the all time high quarterly total liabilities for Altimmune?
- What is Altimmune quarterly total liabilities year-on-year change?
What is Altimmune annual total liabilities?
The current annual total liabilities of ALT is $16.54 M
What is the all time high annual total liabilities for Altimmune?
Altimmune all-time high annual total liabilities is $37.43 M
What is Altimmune quarterly total liabilities?
The current quarterly total liabilities of ALT is $14.49 M
What is the all time high quarterly total liabilities for Altimmune?
Altimmune all-time high quarterly total liabilities is $39.14 M
What is Altimmune quarterly total liabilities year-on-year change?
Over the past year, ALT quarterly total liabilities has changed by -$2.05 M (-12.42%)